Evidence map›Paper›PMID 41988120›Full record

ArticleFrontiers in oncology2026

PRECEDE-PROCEED model for discharge preparation in first-cycle colorectal cancer chemotherapy: a quasi-experimental study.

Xiuhua Chen, Huangjing Chen, Wangjuan She, Yeping Ge, Bihe Qiu, Wei Zhu, Haiyan Gu

Abstract read
In one paragraph

Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Xiuhua Chen *Department of Oncology, Affiliated Hospital No. 2 of Nantong University, Nantong First People's Hospital, Nantong, China.
Huangjing Chen *Department of Ultrasound, Affiliated Hospital of Nantong University, Nantong, China.
Wangjuan SheDepartment of Oncology, Affiliated Hospital No. 2 of Nantong University, Nantong First People's Hospital, Nantong, China.
Yeping GeDepartment of Oncology, Affiliated Hospital No. 2 of Nantong University, Nantong First People's Hospital, Nantong, China.
Bihe QiuDepartment of Oncology, Affiliated Hospital No. 2 of Nantong University, Nantong First People's Hospital, Nantong, China.
Wei ZhuDepartment of Oncology, Affiliated Hospital No. 2 of Nantong University, Nantong First People's Hospital, Nantong, China.
Haiyan GuDepartment of Nursing, Affiliated Hospital No. 2 of Nantong University, Nantong First People's Hospital, Nantong, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: The aim of this study was to evaluate the impact of discharge preparation guided by the PRECEDE-PROCEED model of health education in patients with colorectal cancer undergoing their first cycle of chemotherapy. Methods: A total of 168 patients with colorectal cancer receiving their first chemotherapy cycle in the Department of Medical Oncology between January and August 2025 were assigned to either the control group ( Results: Patients in the experimental group demonstrated significantly higher mean scores for total hospital discharge readiness (100.70 ± 3.80 vs 85.77 ± 3.53, Conclusion: Health education based on the PRECEDE-PROCEED model enhanced discharge readiness, the quality of discharge guidance, and the home care experience of patients with colorectal cancer receiving their first cycle of chemotherapy, although it did not significantly reduce unplanned readmission within 3 weeks. These findings suggest that integrating the PRECEDE-PROCEED model into discharge preparation may serve as a low-cost, high-impact intervention to improve transition safety and patient experience in first-cycle CRC chemotherapy.

Indexed as

Colorectal cancerdischarge preparationfirst cycle of chemotherapyhealth educationPRECEDE-PROCEED model

Identifiers

PMID41988120
PMCPMC13076130

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.